Emotional perspective from the use of technology
DOI:
https://doi.org/10.47196/diab.v56i3Sup.589Keywords:
diabetes mellitus, tecnologyAbstract
Diabetes technology generally yields favourable results in terms of self-reported outcomes such as reduced diabetes distress, improved treatment satisfaction or reduced depression. This holds true for CSII and CGM, as well as for automated insulin delivery systems, albeit evidence for the latter is still limited.
Irrespective of the type of thecnology, a most intriguing and clinically relevant finding pertains to interindividual variability in diabetes thecnology uptake.Not all individuals use CSII or CGM consequentially (in terms of time the devices are used) and, therefore, cannot benefit from CSII or CGM to the full extent. It remains to be fully clarified as to why some individuals do not engage with diabetes technologies or even discontinue their use altogether, Furthermore, healthcare professionals need to be able to provide education about technologies; however, not all are able to discuss CGM/pump/automated insulin delivery system data.
References
I. Kubiak T, Priesterroth L, Barnard-Kelly KD. Psychosocial aspects of diabetes technology. Diabet Med 2020;37(3):448:545. doi: 10.1111/dme.14234.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
